Skip to main content
Log in

Pre-pubertal growth in the hyperprostaglandin E syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Pre-pubertal body growth was followed in eight children with the hyperprostaglandin E syndrome (neonatal Bartter syndrome) treated with indomethacin over a period of 5–12 years. When corrected for prematurity, the general growth pattern was normal, with the exception of a child with delayed therapy. From the first observation (usually at birth) to the start of indomethacin, the mean height standard deviation score (SDS) corrected for prematurity changed from −0.2 to −2.8. During the first 2 years of therapy rapid catch-up growth occurred, followed by a slow adaptation of the growth pattern to that of healthy children born at term. At last observation the mean corrected height SDS was −0.5 range −1.9 to +0.9) and the mean target height −0.9 SDS (range −1.8 to +0.1). Weight, body mass index and bone maturation also reached the normal range. No correlation was found between height SDS per year and serum potassium levels or calcium excretion. We conclude that under indomethacin treatment long-term skeletal growth of children with the hyperprostaglandin E syndrome is similar to that of other preterm children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K (1985) Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter's syndrome. J Pediatr 107: 694–701

    Google Scholar 

  2. Seyberth HW, Königer SJ, Rascher W, Kühl PG, Schweer H (1987) Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1: 491–497

    Google Scholar 

  3. Fanconi A, Schachenmann G, Nüssli R, Prader A (1971) Chronic hypokalaemia with growth retardation, normotensive hyperreninhyperaldosteronism (“Bartter's syndrome”), and hypercalciuria. Report of two cases with emphasis on natural history and on catch-up growth during treatment. Helv Paediatr Acta 27 2: 144–163

    Google Scholar 

  4. Bartter FC, Pronove P, Gill JR, MacCardle RC (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33: 811–828

    Google Scholar 

  5. Royer P, Delaitre R, Mathieu H, Gabilan JC, Raynoud C, Pasqualini JR (1964) L'hypokaliemie chronique idiopathique avec hyperkaliurie de l'enfant. Rev Fr Etud Clin Biol 9: 61–87

    Google Scholar 

  6. Rodriguez-Soriano J (1994) Tubular disorders of electrolyte regulation. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric Nephrology, 3rd edn. Williams and Wilkins, Baltimore, pp 624–639

    Google Scholar 

  7. Simopoulos AP, Bartter FC (1972) Growth characteristics and factors influencing growth in Bartter's syndrome. J Pediatr 81: 56–65

    Google Scholar 

  8. Littlewood JM, Lee MR, Meadow SR (1978) Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Arch Dis Child 53: 43–48

    Google Scholar 

  9. Floret D, David M, Roux A, Hage G-N, Teyssier G (1979) Bartter's syndrome: the long-term effects of indomethacin on growth. Nouv Presse Med 8: 17–21

    Google Scholar 

  10. Lechacz G, Arbus GS, Balfe JW, Wolff ED, Robson L (1979) Effect of ibuprofen on growth in a child with Bartter syndrome. J Pediatr 95: 319–320

    Google Scholar 

  11. Cunningham RJ, Brouhard BH, Berger M, Petrusick T, Travis LB (1979) Long-term use of propranolol, ibuprofen and spironolactone in the management of Bartter's syndrome. Pediatrics 63: 754–756

    Google Scholar 

  12. Simopoulos AP (1979) Growth characteristics in patients with Bartter's syndrome. Nephron 23: 130–135

    Google Scholar 

  13. Proesmans W, Massa G, Vanderschueren-Lodeweyckx M (1988) Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 2: 205–209

    Google Scholar 

  14. Dillon MJ, Shah V, Mitchell MD (1979) Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. Medicine (Baltimore) 48: 429–446

    Google Scholar 

  15. Ohlsson A, Sieck U, Cumming W, Akhtar M, Serenius F (1984) A variant of Bartter's syndrome. Acta Paediatr Scand 73: 868–874

    Google Scholar 

  16. De Rovetto CR, Welch TR, Hug G, Clark KE, Bergstrom W (1989) Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 115: 397–404

    Google Scholar 

  17. Deschenes G, Burguet A, Guyot C, Hubert P, Garabedian M, Dechaux M, Loirat C, Broyer M (1993) Antenatal form of Bartter syndrome. Ann Pediatr (Paris) 40: 95–101

    Google Scholar 

  18. Leonhardt A, Busch C, Timmermanns G, Roth B, Seyberth HW (1992) Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr 120: 546–554

    Google Scholar 

  19. Ellimann AM, Bryan EM, Ellimann AD, Harvey DR (1992) Gestational age correction for height in preterm children to seven years of age. Acta Paediatr 81: 836–839

    Google Scholar 

  20. Albertsson-Wikland K, Wennergren G, Wennergren M, Vilbergsson G, Rosberg S (1993) Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatr 82: 438–443

    Google Scholar 

  21. Prader A, Largo RH, Molinari L, Issler C (1988) Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta [Suppl] 52: 1–125

    Google Scholar 

  22. Brandt I (1978) Growth dynamics of low-birth-weight-infants with emphasis on the perinatal period. In: Falkner F, Tanner JM (eds) Human growth, vol 2. Plenum, New York, pp 577–617

    Google Scholar 

  23. Largo RH, Wälli R, Duc G, Fanconi A, Prader A (1980) Evaluation of perinatal growth. Helv Paediatr Acta 35: 419–436

    Google Scholar 

  24. Georgi M, Kattwinkel I (1994) Normwerte von Körpergröße, Körpergewicht und Körperzusammensetzung bei Kindern und Jugendlichen im Großraum Heidelberg unter Berücksichtigung der bioelektrischen Impedanz-Analyse. Dissertation University of Heidelberg, Germany

  25. Patriquin H, Robitaille P (1986) Renal calcium deposits in children: sonographic demonstration of the Anderson-Carr progression. AJR 146: 1253–1256

    Google Scholar 

  26. Gasser T, Köhler W, Müller HG, Kneip A, Largo R, Molinari L (1984) Velocity and acceleration of height growth using kernel estimation. Ann Hum Biol 11: 397–411

    Google Scholar 

  27. Gasser T (1991) Analysing curves using kernel estimators. Pediatr Nephrol 5: 477–450

    Google Scholar 

  28. Seidel C, Schaefer F, Schärer K (1993) Body growth in urinary tract malformations. Pediatr Nephrol 7: 151–155

    Google Scholar 

  29. Tanner JMI, Goldstein H, Whitehouse RH (1970) Standards for children's height at ages 2–9 years allowing for height of parents. Arch Dis Child 45: 755–762

    Google Scholar 

  30. Molinari L, Largo RH, Prader A (1985) Target height and secular trend in the Swiss population. In: J Borms et al. (eds) Human growth and development. Plenum, New York, pp 193–200

    Google Scholar 

  31. Trygstad CW, Mangos JA, Bloodworth JMB, Lobeck CC (1969) A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting. Pediatrics 44: 234–242

    Google Scholar 

  32. James T, Holland NH, Preston D (1975) Bartter syndrome: typical facies and normal plasma volume. Am J Dis Child 129: 1205–1207

    Google Scholar 

  33. McCredia DA, Rotenberg E, Williams AL (1974) Hypercalciuria in potassium-losing nephropathy: a variant of Bartter's syndrome. Aust J Med 10: 286–295

    Google Scholar 

  34. Girardin E, Favre L, Vallotton MB, Paunier L (1986) Familial Bartter's syndrome: report of a case with early manifestations and persistent hypercalciuria. Helv Paediatr Acta 41: 221–228

    Google Scholar 

  35. West CD, Smith WC (1956) An attempt to elucidate the cause of growth retardation in renal disease. Am J Dis Child 91: 460–467

    Google Scholar 

  36. Uttley WS, Paxton J, Thistlethwaite (1972) Urinary concentrating ability and growth failure in urinary tract disorders. Arch Dis Child 47: 436–441

    Google Scholar 

  37. Shoemaker L, Welch TR, Bergstrom W, Abrams A, Yergey AL, Viera N (1993) Calcium kinetics in the hyperprostaglandin E syndrome. Pediatr Res 33: 92–96

    Google Scholar 

  38. Albertsson-Wikland K, Karlberg J (1994) Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr [Suppl] 399: 64–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seidel, C., Reinalter, S., Seyberth, H.W. et al. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 9, 723–728 (1995). https://doi.org/10.1007/BF00868723

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00868723

Key words

Navigation